| abstract |
the present generally relates to compositions that include antibodies, for example, humanized monoclonal, chimeric antibodies, antibody fragments, etc., which specifically bind to one or more epitopes within a cd33 protein, for example, human cd33 or a mammalian cd33, and have enhanced and / or enhanced functional characteristics, and the use of these compositions in preventing, reducing risk, or treating an individual in need of them. |